William Plovanic Net Worth

The estimated Net Worth of William J. Plovanic is at least $296 Thousand dollars as of 12 November 2019. Mr. Plovanic owns over 65,000 units of Obalon Therapeutics Inc stock worth over $295,853 and over the last 8 years he sold OBLN stock worth over $0. In addition, he makes $0 as Director at Obalon Therapeutics Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Plovanic OBLN stock SEC Form 4 insiders trading

William has made over 3 trades of the Obalon Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 65,000 units of OBLN stock worth $107,900 on 12 November 2019.

The largest trade he's ever made was buying 65,000 units of Obalon Therapeutics Inc stock on 12 November 2019 worth over $107,900. On average, William trades about 8,958 units every 51 days since 2016. As of 12 November 2019 he still owns at least 106,806 units of Obalon Therapeutics Inc stock.

You can see the complete history of Mr. Plovanic stock trades at the bottom of the page.

William Plovanic biography

William J. Plovanic has been appointed as Director of the Company effective 6/29/2020. Previously, Mr. Plovanic served as Managing Director, Medical Technology Equity Research at Canaccord Genuity Inc., an investment bank, from February 2007 to March 2016. Prior to Canaccord Genuity, Mr. Plovanic served in various roles at First Albany Capital Inc. from February 2001 to February 2007, including as Managing Director, Equity Research. Mr. Plovanic holds a B.S. from Bradley University and is a CFA charterholder.

How old is William Plovanic?

William Plovanic is 47, he's been the Director of Obalon Therapeutics Inc since 2020. There are 10 older and 2 younger executives at Obalon Therapeutics Inc. The oldest executive at Obalon Therapeutics Inc is Raymond Dittamore, 73, who is the Independent Director.

What's William Plovanic's mailing address?

William's mailing address filed with the SEC is 5421 Avenida Encinas f, Carlsbad, CA 92008, USA.

Insiders trading at Obalon Therapeutics Inc

Over the last 8 years, insiders at Obalon Therapeutics Inc have traded over $0 worth of Obalon Therapeutics Inc stock and bought 3,260,355 units worth $6,939,913 . The most active insiders traders include Parters Vii L Pblair James ..., Partners X Lp Inter West Ma..., and David Moatazedi. On average, Obalon Therapeutics Inc executives and independent directors trade stock every 54 days with the average trade being worth of $432,771. The most recent stock trade was executed by William J. Plovanic on 12 November 2019, trading 65,000 units of OBLN stock currently worth $107,900.

What does Obalon Therapeutics Inc do?

Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.

Complete history of Mr. Plovanic stock trades at Obalon Therapeutics Inc

Obalon Therapeutics Inc executives and stock owners

Obalon Therapeutics Inc executives and other stock owners filed with the SEC include:

• Dr. Kelly Huang Ph.D.,
  Consultant
• Andrew Rasdal,
  Chairman of the Board, President, Chief Executive Officer
• Andrew P. Rasdal,
  CEO, Pres & Director
• Sharon Stevenson,
  Independent Director
• Lesley Howe,
  Independent Director
• Douglas Fisher,
  Independent Director
• Raymond Dittamore,
  Independent Director
• William Plovanic,
  Director
• Robert MacDonald,
  Chief Retail Officer
• Donald Young,
  Vice President of Quality Assurance
• Todd Wood,
  Vice President - Global Sales
• Lisa Metzner,
  Vice President of Marketing
• Matthew Norwood,
  Vice President of Sales
• Steve Johnson,
  Vice President - Operations
• Nooshin Hussainy,
  Chief Financial Officer
• Nooshin Hussainy,
  CFO & Sec.
• Kim P. Kamdar,
  
• Erin Morisey,
  VP Strategic Partnerships
• Partners X Lp Inter West Ma...,
  
• David Moatazedi,
  
• Vii Associates Lpblair Jame...,
  
• Parters Vii L Pblair James ...,
  
• Amy Vanden Berg,
  Chief Clinical & Reg Officer
• Kelly Huang,
  Pres & Chief Executive Officer
• Robert H Jr Mondore,
  VP of Operations
• Jonah Shacknai,
  
• Partners X Lp Inter West Ma...,
  
• Daina Schmidt,
  Vice President of Marketing
• Mark Brister,
  Chief Technology Officer